Ligand Presents Positive Results from Phase 1 Clinical Trial of Captisol-enabled Iohexol
Biospace,
SAN DIEGO--( BUSINESS WIRE )-- Ligand Pharmaceuticals Inc. (NASDAQ: LGND) presented positive results today from a Phase 1…
Ligand Presents Positive Results from Phase 1 Clinical Trial of Captisol-enabled Iohexol
NASDAQ,
Presentation at the American Society of Nephrology (ASN) Kidney Week 2019 SAN DIEGO --(BUSINESS WIRE)-- Ligand Pharmaceuticals…
Ligand Presents Positive Results from Phase 1 Clinical Trial of Captisol-enabled Iohexol
Weather herald,
SAN DIEGO--()-- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) presented positive resultstoday from a Phase 1 clinical…
Ligand Presents Positive Results from Phase 1 Clinical Trial of Captisol-enabled Iohexol
Jotup,
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) presented positive results today from a Phase 1 clinical trial of its…
Ligand Presents Positive Results from Phase 1 Clinical Trial of Captisol-enabled Iohexol
Erie News Now,
Presentation at the American Society of Nephrology (ASN) Kidney Week 2019 Presentation at the American Society of Nephrology (ASN…
Ligand Presents Positive Results from Phase 1 Clinical Trial of Captisol-enabled Iohexol
TulsaCW,
Presentation at the American Society of Nephrology (ASN) Kidney Week 2019 SAN DIEGO --(BUSINESS WIRE) Ligand Pharmaceuticals…
Ligand Presents Positive Results from Phase 1 Clinical Trial of Captisol-enabled Iohexol
Fox 21 Delmarva,
Presentation at the American Society of Nephrology (ASN) Kidney Week 2019 SAN DIEGO --(BUSINESS WIRE) Ligand Pharmaceuticals…
Ligand Presents Positive Results from Phase 1 Clinical Trial of Captisol-enabled Iohexol
Digital Journal,
SAN DIEGO--(Business Wire)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) presented positive results today from a Phase 1…
Ligand Presents Positive Results from Phase 1 Clinical Trial of Captisol-enabled Iohexol
Morning Star,
Presentation at the American Society of Nephrology (ASN) Kidney Week 2019 Ligand Pharmaceuticals Incorporated (NASDAQ: LGND…
Ligand Presents Positive Results from Phase 1 Clinical Trial of Captisol-enabled Iohexol
Business Wire,
Presentation at the American Society of Nephrology (ASN) Kidney Week 2019 SAN DIEGO--( BUSINESS WIRE )-- Ligand Pharmaceuticals…
Ligand Announces Positive Top Line Results from Phase 1 Clinical Trial of Captisol-enabled Iohexol
Biospace,
13:00 UTC SAN DIEGO--( BUSINESS WIRE )-- Ligand Pharmaceuticals Inc. (NASDAQ: LGND) today announced positive top line results…
Ligand Announces Positive Top Line Results from Phase 1 Clinical Trial of Captisol-enabled Iohexol
Yahoo! Finance USA,
Study achieved primary endpoint demonstrating pharmacokinetic bioequivalence between Captisol-enabled Iohexol and OMNIPAQUE™…
Ligand Announces Positive Top Line Results from Phase 1 Clinical Trial of Captisol-enabled Iohexol
Business Wire,
Study achieved primary endpoint demonstrating pharmacokinetic bioequivalence between Captisol-enabled Iohexol and OMNIPAQUE™…
Ligand Announces Positive Top Line Results from Phase 1 Clinical Trial of Captisol-enabled Iohexol
NASDAQ,
Study achieved primary endpoint demonstrating pharmacokinetic bioequivalence betweenCaptisol-enabled Iohexol and OMNIPAQUE™ SAN…
Ligand Completes Enrollment of Phase 1 Clinical Trial of Captisol-enabled Iohexol
Biospace,
13:00 UTC Top-line data expected Q3 of 2019 Also reports recent results from clinician survey on radiocontrast agent selection…
Ligand Completes Enrollment of Phase 1 Clinical Trial of Captisol-enabled Iohexol - Press Release
Digital Journal,
SAN DIEGO--(Business Wire)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces completion of enrollment of the Company…
Ligand Completes Enrollment of Phase 1 Clinical Trial of Captisol-enabled Iohexol
Yahoo! Finance USA,
SAN DIEGO--(BUSINESS WIRE)--Top-line data expected Q3 of 2019Also reports recent results from clinician survey on radiocontrast…
Ligand Completes Enrollment of Phase 1 Clinical Trial of Captisol-enabled Iohexol
Business Wire,
Top-line data expected Q3 of 2019 Also reports recent results from clinician survey on radiocontrast agent selection and use…
Ligand Completes Enrollment of Phase 1 Clinical Trial of Captisol-enabled Iohexol
NASDAQ,
Also reports recent results from clinician survey on radiocontrast agent selection and use SAN DIEGO--(BUSINESS WIRE)-- Ligand…